Skip to content
All guides
Harm reduction

How to Prepare for a Psychedelic Experience

Practical preparation for a lawful setting: choosing where, medical screening, the weeks before, deposits and travel, what to bring and what to ask the provider.

Editorial Team6 min readUpdated

What this guide covers

This guide is about the practical work before a session in a setting where it is lawful or openly tolerated: a licensed psilocybin service centre in Oregon or Colorado, a retreat abroad, a clinical trial, or ketamine treatment at a clinic. It does not give doses or advice for illegal use.

Two other articles cover the psychology of the day itself. Set and setting explains why mindset and surroundings matter, and challenging experiences covers what to do when a session turns difficult. This page is the checklist that comes before both.

Formal programmes treat preparation as part of the treatment, not an extra. In Oregon a client must attend a preparation session with a licensed facilitator before any administration session. (Oregon State Legislature, current edition) In the phase 3 MDMA trial for severe PTSD, each participant had three preparatory therapy sessions before the first medicine session. (Nature Medicine, 2021)

Choose where, starting with the law

The legal footing differs more than most marketing suggests, so start there. The is it legal tool and the legal overview set out the position place by place with sources.

For a broad view of what centres charge, the Q4 2026 report gives published prices per night by country.

Medical screening before you book

Screening belongs before you pay a deposit, not on arrival. Rather than repeat it here, work through the screening checklist and check every medicine and supplement you take in the interaction checker.

A few points decide many cases. Oregon's required client form rules out anyone who has taken lithium in the last 30 days, who has ever had active psychosis, or who currently has thoughts of harming themselves or others. (Oregon Health Authority, Public Health Division, 2026) In an online survey of 541 people with bipolar disorder who had used psilocybin, 32.2% described new or worse symptoms afterwards. (Journal of Psychopharmacology, 2023) Ayahuasca's MAO-inhibiting alkaloids combined with SSRI antidepressants may cause serotonin syndrome. (Journal of Psychoactive Drugs, 1998; ICEERS, 2026) Ibogaine carries a cardiac risk that calls for an ECG and blood tests first; the ibogaine clinic safety guide explains why. (Global Ibogaine Therapy Alliance (Internet Archive copy), 2016)

If a medicine is a problem, the answer is a conversation with the doctor who prescribed it. ICEERS says some antidepressants may need to be stopped at least two weeks before ayahuasca, but only under strict medical supervision, because stopping psychiatric medication abruptly can be dangerous. (ICEERS, 2018) Never change a dose on your own to make yourself eligible.

The weeks before

Intentions. Most programmes ask you to think about why you are going. Write down what you hope for and what you are afraid of, in plain words, and bring it to the preparation session. An honest answer to "why now?" is more useful than a polished one.

Diet and abstinence. Some ayahuasca centres publish a diet to follow for days or weeks beforehand. The reason usually given is tyramine, found in foods such as aged cheese, soy sauce and some meats. ICEERS says large amounts of tyramine with ayahuasca can, in rare cases, cause a dangerous rise in blood pressure, but that the MAO inhibitors in the brew clear relatively quickly, so poisoning from food eaten before or after a session is unlikely. (ICEERS, 2018; Journal of Ethnopharmacology, 1999) Strict diets rest more on tradition and caution than on measured risk. Preparing for Rythmia sets one centre's diet next to what the pharmacology says. ICEERS also advises avoiding alcohol, stimulants, opioids and other drugs in the days or weeks before an ayahuasca session, and that advice has a firmer basis. (ICEERS, 2018)

For ketamine the instructions are clinical. The Spravato label tells patients to avoid food for at least 2 hours and drinks for at least 30 minutes before a dose, because of nausea. (U.S. National Library of Medicine, DailyMed (Janssen label), 24 Sep 2026)

Your own life. If you are in an acute crisis, ask the provider whether waiting would be wiser. Tell one person at home where you will be and how to reach the centre.

Money, deposits and travel

Read the booking terms before you pay. Points to settle in writing:

  • Deposit and refund. How much is due now, and what you get back if you withdraw or if their screening turns you down after you have paid. A centre that screens properly will sometimes say no, and the refund terms should allow for that.
  • What the price covers. Accommodation, transfers, food, integration calls, and any extra ceremonies or medicines.
  • Travel insurance. Read the exclusions, ask the insurer directly whether a retreat or treatment abroad is covered, and keep the answer in writing.
  • Getting home. Do not book a flight for the morning after the last session. With Spravato, the label says not to drive until the next day after a restful sleep, and the same caution is sensible after any session. (U.S. National Library of Medicine, DailyMed (Janssen label), 24 Sep 2026)

In Oregon, centres do not have to report what sessions cost, so ask for the full price in writing. (Oregon Health Authority, 2026) Clinical trials vary as well: the National Institute on Aging suggests asking whether taking part costs anything and whether travel, lodging and meals are reimbursed. (National Institute on Aging (NIH), current page)

What to bring

  • A written list of every medicine, supplement and dose, and your prescriber's contact details.
  • Any medical letters or test results the provider asked for.
  • Comfortable, loose clothes and warm layers.
  • An eye mask, a notebook and a pen.
  • Enough of your regular medicines for the whole stay, in original packaging.
  • The address and phone number of the nearest hospital, and an emergency contact the staff can call.

Leave anything that would make you anxious to lose, and check whether the centre allows phones in the ceremony space.

Questions to ask the provider

No outside body checks the quality of most retreat ceremonies, including intake, aftercare and the number of sober staff present. (DRUGSinfo (Drugs Infolijn), Trimbos-instituut) Your questions are the check. Ask:

  1. Who screens me, what are their qualifications, and what makes you turn someone away?
  2. How many staff stay sober during a session, and how many guests are there?
  3. Who has medical training on site, and how far is the nearest hospital?
  4. What is your written plan for a medical emergency, and when did you last use it?
  5. What is your policy on touch? Chacruna's community guide warns that sessions alone with a healer have been a common setting for sexual abuse, and that sexual contact during or after a ceremony is not acceptable in ayahuasca traditions. (Chacruna Institute for Psychedelic Plant Medicines, 2018)
  6. What happens after I leave: is there follow-up, and with whom?
  7. Do you add other substances, such as tobacco purges, kambo or 5-MeO-DMT? Each carries its own risks, and a published autopsy case attributed a death to 5-MeO-DMT taken with the harmala alkaloids found in ayahuasca. (Journal of Analytical Toxicology, 2005; ICEERS, 2023)

Vague answers, pressure to book quickly or advice to stop a medicine without your doctor are reasons to look elsewhere.

The day before and the days after

Sleep, eat as instructed and arrive early enough to settle in. Unsupervised use carries more risk: in the Global Ayahuasca Survey, taking ayahuasca without supervision was linked to more physical adverse effects. (PLOS Global Public Health, 2022) If you are supporting someone else, the trip sitter's guide covers that role.

Clear at least two days afterwards with no work or travel. Oregon facilitators must offer an integration session after the administration session, although taking it up is optional. (Oregon State Legislature, current edition) What helps in the weeks after is covered in integration practices.

If you are weighing a retreat, Rythmia offers ayahuasca in Costa Rica and is a Peyote.com partner.

Related

Questions and answers

How far in advance should I prepare for a psychedelic retreat?
Start several weeks ahead, because medical screening and any change to medication need time with your own doctor. ICEERS says some antidepressants may need to be stopped at least two weeks before ayahuasca, and only under strict medical supervision. Book only after screening, so a refusal does not cost you a deposit.Source: ICEERS, 2018Pre-retreat screening checklist
Why do ayahuasca retreats ask you to follow a diet beforehand?
The usual reason given is tyramine, found in aged cheese, cured meat and some drinks, which can raise blood pressure with MAO inhibitors. ICEERS says this happens only rarely with ayahuasca because its MAO inhibitors clear relatively quickly, so strict diets rest more on tradition and caution than on measured risk. Avoiding alcohol and other drugs beforehand is better supported.Sources: ICEERS, 2018; Journal of Ethnopharmacology, 1999
Is there a preparation session before legal psilocybin in Oregon?
Yes. Under Oregon law a client must attend a preparation session with a licensed facilitator before any administration session, and must complete a client information form. Lithium in the last 30 days, any history of active psychosis or current thoughts of harming self or others rule a session out.Sources: Oregon State Legislature, current edition; Oregon Health Authority, Public Health Division, 2026Legal psilocybin in the US
Can I drive home after a ketamine or esketamine treatment?
Not on the same day. The Spravato (esketamine) label says patients should not drive or operate machinery until the next day after a restful sleep, and must be observed for at least 2 hours after each dose before leaving. Arrange a lift or other transport home before the appointment.Source: U.S. National Library of Medicine, DailyMed (Janssen label), 24 Sep 2026Ketamine therapy guide

Sources

  1. ORS Chapter 475A - Psilocybin (ORS 475A.220, 475A.345, 475A.360). Oregon State Legislature, current edition
  2. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine, 2021
  3. Client Information Form (Oregon Psilocybin Services, updated 1.1.26). Oregon Health Authority, Public Health Division, 2026
  4. Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. Journal of Psychoactive Drugs, 1998
  5. Ayahuasca Safety Profile. ICEERS, 2026
  6. Deciding to Take Ayahuasca. ICEERS, 2018
  7. Paddo's: Risico's. DRUGSinfo (Drugs Infolijn), Trimbos-instituut
  8. OAR 333-333 permanent rules (PH 15-2025, tracked changes). Oregon Health Authority / Oregon Secretary of State, 2025
  9. Senate Bill 23-290 (signed act). Colorado General Assembly, 23 May 2023
  10. The DOR's Natural Medicine Division issues Colorado's first healing center license. Colorado Department of Revenue, Natural Medicine Division, 2 Apr 2025
  11. 21 U.S. Code 812 - Schedules of controlled substances. Legal Information Institute (Cornell) reproducing the U.S. Code, current text
  12. Declaran Patrimonio Cultural de la Nacion a los conocimientos y usos tradicionales del Ayahuasca. Agencia Peruana de Noticias Andina (state news agency), 12 Jul 2008
  13. Disenos materiales e inmateriales: la patrimonializacion del kene shipibo-konibo y de la ayahuasca en el Peru (Luisa Elvira Belaunde). Ministerio de Cultura del Peru, Centro de Recursos (hosted academic article), 2012
  14. Advertencia Sanitaria sobre uso, Consumo, y Publicidad de Ayahuasca e Ibogaina. Ministerio de Salud de Costa Rica, 27 Jan 2025
  15. Truffels & paddo's en de wet. Jellinek, current page
  16. Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica's Unregulated Psilocybin Industry as FDA Approval Nears (Kyle Spohn). University of Miami Inter-American Law Review, 2025
  17. Full Text | Health ministry warns against magic mushrooms. Jamaica Gleaner, 24 Aug 2024
  18. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA, 2023
  19. ClinicalTrials.gov fact sheet. U.S. National Library of Medicine (NIH), Oct 2023
  20. 21 CFR 1308.13 - Schedule III. eCFR (Office of the Federal Register), current
  21. SPRAVATO (esketamine) nasal spray, prescribing information (DailyMed, version published 24 Sep 2026). U.S. National Library of Medicine, DailyMed (Janssen label), 24 Sep 2026
  22. FDA warns patients and health care providers about potential risks associated with compounded ketamine products, including oral formulations, for the treatment of psychiatric disorders (Internet Archive copy of the FDA page, captured 6 Jan 2026; the fda.gov URL returned 404 on 26 Oct 2026). U.S. Food and Drug Administration, 10 Oct 2023
  23. Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. Journal of Psychopharmacology, 2023
  24. Clinical Guidelines for Ibogaine-Assisted Detoxification, 1st Edition, Version 1.1. Global Ibogaine Therapy Alliance (Internet Archive copy), 2016
  25. Pharmacokinetics of Hoasca alkaloids in healthy humans. Journal of Ethnopharmacology, 1999
  26. Oregon Psilocybin Services 2025 Year-End Data Summary Document. Oregon Health Authority, 2026
  27. What Are Clinical Trials and Studies?. National Institute on Aging (NIH), current page
  28. Ayahuasca Community Guide for the Awareness of Sexual Abuse. Chacruna Institute for Psychedelic Plant Medicines, 2018
  29. A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. Journal of Analytical Toxicology, 2005
  30. Examining the Deaths Misattributed to Ayahuasca. ICEERS, 2023
  31. Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Global Public Health, 2022

The dispatch

Laws change. Centres change. Know before you book.

A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.

Educational only. Not medical advice. Unsubscribe any time.